Loading
Sidney Kimmel Comprehensive Cancer Center at Jefferson Health
Thomas Jefferson University's NCI-designated cancer centre, known for prostate cancer biology and GUCY2C-targeted colorectal cancer immunotherapy.
Also called: SKCC Jefferson
Overview
NCI-designated since 1996, the Sidney Kimmel Comprehensive Cancer Center serves Philadelphia and southern New Jersey through Jefferson Health's hospital network. Scott Waldman identified guanylyl cyclase C (GUCY2C) as a colorectal cancer antigen and has carried vaccines and CAR-T against it into trials. Karen Knudsen, former director and later CEO of the American Cancer Society, built its androgen receptor and prostate cancer programme with urologist Leonard Gomella; Adam Dicker leads radiation oncology. The centre is a member of the NCI's cooperative group network and runs a community outreach programme across its catchment.
Location
Philadelphia, PA, US
Type
cancer center · Thomas Jefferson University
Newsweek 2026 oncology rank
Not in top 300 listing used
NCI designation
comprehensive
OnCo score
#172 · 31 points (0 Newsweek + 15 NCI + 16 from 8 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-08.
Matched to Thomas Jefferson University Hospital, including child institutions. 247 works · 1,453 citations · 55% open access · 8% clinical trials · 6% reviews.
Oncology works per year
422022
482023
462024
632025
482026
Most works
- Harish Lavu19 works
- Alexander Schlachterman15 works
- Charles J. Yeo15 works
- Avinoam Nevler13 works
- Faisal Kamal13 works
- Thomas E. Kowalski11 works
- Joseph Curry8 works
- Neethi R. Dasu8 works
- Adam Luginbuhl8 works
- Yasi Xiao8 works
Most cited
Programmes
3- Prostate cancer and AR biology
- GUCY2C immunotherapy
- Radiation oncology
People
2Marcia S. Brose
Chair of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson Health
Thyroid cancerKinase inhibitorsPrecision oncology
Led DECISION, the trial that made sorafenib the first approved targeted drug for radioiodine-refractory thyroid cancer.
Sidney Kimmel
Founder of the Sidney Kimmel Foundation for Cancer Research; namesake of the Johns Hopkins cancer centre and Jefferson's medical college
Cancer research philanthropyYoung investigator fundingCancer immunotherapy
The Jones Apparel founder has given $157 million to Johns Hopkins since 2001, which named its cancer centre for him, and put $50 million into the Bloomberg~Kimmel Institute for Cancer Immunotherapy in 2016.
Connected
10Similar pages
- PersonJames L. Gulley
Shares Off-the-shelf cancer vaccines, National Cancer Institute (NIH), Prostate cancer.
- CompanyVeru
Shares Androgen receptor, Prostate cancer.
- InstitutionMayo Clinic Comprehensive Cancer Center in Florida
Shares Off-the-shelf cancer vaccines, National Cancer Institute (NIH), CAR-T cell therapy.
- CompanyAdventris Pharmaceuticals
- Target5-alpha-reductase type 2 (SRD5A2)
Shares Androgen receptor, Prostate cancer.
- PersonEric J. Small
Shares Androgen receptor, Prostate cancer.
- TreatmentAZD9750
Shares Androgen receptor, Prostate cancer.
- TreatmentQLH12016
Shares Androgen receptor, Prostate cancer.
cancers
fronts
technologies
targets
institutions
people
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
jeffersonhealth.org · 1
A source that has moved or gone is reported by the weekly link check. /audit/